Skip to main content
SpringerLink
Log in

Outpatient Pharmacotherapy and Modes of Administration for Acute Repetitive and Prolonged Seizures

  • Review Article
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

Acute repetitive seizures (ARS) are a serious epilepsy phenomenon, generally described as closely grouped seizures over minutes to 2 days, representing an increase in seizure frequency compared with baseline. In some instances, ARS may not stop without treatment, and evolution into status epilepticus is a significant concern. Additionally, neuronal injury may occur after even brief repeated seizures. Given the substantial risks that may be involved with ARS, it is crucial to develop appropriate protocols for identification and management of this seizure phenomenon. This article focuses on pharmacotherapy and, in particular, different modes of administering medication for ARS in the outpatient setting. Our aim was to present a review of data from non-randomized and randomized, controlled trials to evaluate the efficacy, safety and tolerability of out-of-hospital ARS treatments. Several of the studies included patients with ARS, as well as patients with prolonged seizures. Prolonged seizures, or seizures lasting greater than 5 min, have similar risks and treatment options to those of ARS; therefore, this discussion also includes treatment trials and recommendations for prolonged seizures. All trials used benzodiazepines, a class of drugs that are ideal for the ARS and prolonged seizure populations because of their rapid onset of action and minimal adverse effects. Rectal diazepam is currently the only formulation approved by the US Food and Drug Administration (FDA) for out-of-hospital treatment. Oral benzodiazepines are appropriate only for mild ARS. Intramuscular diazepam autoinjection has shown success against ARS in clinical trials. Intranasal midazolam and diazepam are in testing. Other treatments have also been explored—specifically, buccal midazolam (approved in the European Union), sublingual lorazepam and intranasal lorazepam.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Martinez C, Sullivan T, Hauser WA. Prevalence of acute repetitive seizures (ARS) in the United Kingdom. Epilepsy Res. 2009;87(2–3):137–43.

    Article  PubMed  Google Scholar 

  2. Haut SR, Lipton RB, LeValley AJ, Hall CB, Shinnar S. Identifying seizure clusters in patients with epilepsy. Neurology. 2005;65(8):1313–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Cereghino JJ. Identification and treatment of acute repetitive seizures in children and adults. Curr Treat Options Neurol. 2007;9(4):249–55.

    Article  PubMed  Google Scholar 

  4. Haut SR, Shinnar S, Moshe SL. Seizure clustering: risks and outcomes. Epilepsia. 2005;46(1):146–9.

    Article  PubMed  Google Scholar 

  5. Haut SR. Seizure clustering. Epilepsy Behav EB. 2006;8(1):50–5.

    Article  Google Scholar 

  6. Haut SR, Shinnar S, Moshe SL, O’Dell C, Legatt AD. The association between seizure clustering and convulsive status epilepticus in patients with intractable complex partial seizures. Epilepsia. 1999;40(12):1832–4.

    Article  CAS  PubMed  Google Scholar 

  7. Mitchell WG. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment. Epilepsia. 1996;37(Suppl 1):S74–80.

    Article  PubMed  Google Scholar 

  8. Haut SR, Veliskova J, Moshe SL. Susceptibility of immature and adult brains to seizure effects. Lancet Neurol. 2004;3(10):608–17.

    Article  PubMed  Google Scholar 

  9. Riss J, Cloyd J, Gates J, Collins S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008;118(2):69–86.

    Article  CAS  PubMed  Google Scholar 

  10. Arendt RM, Greenblatt DJ, Liebisch DC, Luu MD, Paul SM. Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity. Psychopharmacology. 1987;93(1):72–6.

    Article  CAS  PubMed  Google Scholar 

  11. Jones DR, Hall SD, Jackson EK, Branch RA, Wilkinson GR. Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding. J Pharmacol Exp Ther. 1988;245(3):816–22.

    CAS  PubMed  Google Scholar 

  12. Wermeling DP. Intranasal delivery of antiepileptic medications for treatment of seizures. Neurother J Am Soc Exp Neurother. 2009;6(2):352–8.

    Article  CAS  Google Scholar 

  13. Thummel KE, O’Shea D, Paine MF, Shen DD, Kunze KL, Perkins JD, et al. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clini Pharmacol Ther. 1996;59(5):491–502.

    Article  CAS  Google Scholar 

  14. Malinovsky JM, Lejus C, Servin F, Lepage JY, Le Normand Y, Testa S, et al. Plasma concentrations of midazolam after i.v., nasal or rectal administration in children. Br J Anaesth. 1993;70(6):617–20.

    Article  CAS  PubMed  Google Scholar 

  15. Greenblatt DJ, Divoll M. Diazepam versus lorazepam: relationship of drug distribution to duration of clinical action. Adv Neurol. 1983;34:487–91.

    CAS  PubMed  Google Scholar 

  16. Agurell S, Berlin A, Ferngren H, Hellstrom B. Plasma levels of diazepam after parenteral and rectal administration in children. Epilepsia. 1975;16(2):277–83.

    Article  CAS  PubMed  Google Scholar 

  17. Conchie AF, Lowis GR. Diazepam suppositories in prolonged convulsions. Br Med J. 1973;3(5877):457–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. de Boer AG, Moolenaar F, de Leede LG, Breimer DD. Rectal drug administration: clinical pharmacokinetic considerations. Clin Pharmacokinet. 1982;7(4):285–311.

    Article  CAS  PubMed  Google Scholar 

  19. Dhillon S, Ngwane E, Richens A. Rectal absorption of diazepam in epileptic children. Arch Dis Child. 1982;57(4):264–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Knudsen FU. Effective short-term diazepam prophylaxis in febrile convulsions. J Pediatr. 1985;106(3):487–90.

    Article  CAS  PubMed  Google Scholar 

  21. Magnussen I, Oxlund HR, Alsbirk KE, Arnold E. Absorption of diazepam in man following rectal and parenteral administration. Acta Pharmacol Toxicol. 1979;45(2):87–90.

    Article  CAS  Google Scholar 

  22. Milligan N, Dhillon S, Richens A, Oxley J. Rectal diazepam in the treatment of absence status: a pharmacodynamic study. J Neurol Neurosur Psychiatry. 1981;44(10):914–7.

    Article  CAS  Google Scholar 

  23. Milligan NM, Dhillon S, Griffiths A, Oxley J, Richens A. A clinical trial of single dose rectal and oral administration of diazepam for the prevention of serial seizures in adult epileptic patients. J Neurol Neurosur Psychiatry. 1984;47(3):235–40.

    Article  CAS  Google Scholar 

  24. Minagawa K, Miura H, Mizuno S, Shirai H. Pharmacokinetics of rectal diazepam in the prevention of recurrent febrile convulsions. Brain Dev. 1986;8(1):53–9.

    Article  CAS  PubMed  Google Scholar 

  25. Knudsen FU. Plasma-diazepam in infants after rectal administration in solution and by suppository. Acta Paediatr Scand. 1977;66(5):563–7.

    Article  CAS  PubMed  Google Scholar 

  26. Kriel RL, Cloyd JC, Hadsall RS, Carlson AM, Floren KL, Jones-Saete CM. Home use of rectal diazepam for cluster and prolonged seizures: efficacy, adverse reactions, quality of life, and cost analysis. Pediatric Neurol. 1991;7(1):13–7.

    Article  CAS  Google Scholar 

  27. Cloyd JC, Lalonde RL, Beniak TE, Novack GD. A single-blind, crossover comparison of the pharmacokinetics and cognitive effects of a new diazepam rectal gel with intravenous diazepam. Epilepsia. 1998;39(5):520–6.

    Article  CAS  PubMed  Google Scholar 

  28. Cereghino JJ, Mitchell WG, Murphy J, Kriel RL, Rosenfeld WE, Trevathan E. Treating repetitive seizures with a rectal diazepam formulation: a randomized study. The North American Diastat Study Group. Neurology. 1998;51(5):1274–82.

    Article  CAS  PubMed  Google Scholar 

  29. Dreifuss FE, Rosman NP, Cloyd JC, Pellock JM, Kuzniecky RI, Lo WD, et al. A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Eng J Med. 1998;338(26):1869–75.

    Article  CAS  Google Scholar 

  30. Lehmann C, Wannarka GL. Bioavailability and dose proportionality of intramuscular diazepam administered by autoinjector. J Clin Pharmacol. 2008;48(4):436–44.

    Article  CAS  PubMed  Google Scholar 

  31. Divoll M, Greenblatt DJ, Ochs HR, Shader RI. Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex. Anesth Anal. 1983;62(1):1–8.

    Article  CAS  Google Scholar 

  32. Garnett WR, Barr WH, Edinboro LE, Karnes HT, Mesa M, Wannarka GL. Diazepam autoinjector intramuscular delivery system versus diazepam rectal gel: a pharmacokinetic comparison. Epilepsy Res. 2011;93(1):11–6.

    Article  CAS  PubMed  Google Scholar 

  33. Lamson MJ, Sitki-Green D, Wannarka GL, Mesa M, Andrews P, Pellock J. Pharmacokinetics of diazepam administered intramuscularly by autoinjector versus rectal gel in healthy subjects: a phase I, randomized, open-label, single-dose, crossover, single-centre study. Clin Drug Investig. 2011;31(8):585–97.

    Article  CAS  PubMed  Google Scholar 

  34. Abou-Khalil B, Wheless J, Rogin J, Wolter KD, Pixton GC, Shukla RB, et al. A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures. Epilepsia. 2013;54(11):1968–76.

    Article  CAS  PubMed  Google Scholar 

  35. Rogin J, Wheless J, Abou-Khalil B, Wolter KD, Pixton GC, Sherman NA, et al. Safety and effectiveness of long-term treatment with diazepam auto-injector administered by caregivers in an outpatient setting for the treatment of acute repetitive seizures. Epilepsia. 2014;55(9):1444–51.

  36. Agarwal SK, Kriel RL, Brundage RC, Ivaturi VD, Cloyd JC. A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers. Epilepsy Res. 2013;105(3):362–7.

    Article  CAS  PubMed  Google Scholar 

  37. Henney HR, 3rd, Sperling MR, Rabinowicz AL, Bream G, Carrazana EJ. Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults. Epilepsy Res. 2014;108(7):1204–11.

  38. Ivaturi V, Kriel R, Brundage R, Loewen G, Mansbach H, Cloyd J. Bioavailability of intranasal vs rectal diazepam. Epilepsy Res. 2013;103(2–3):254–61.

    Article  CAS  PubMed  Google Scholar 

  39. Sperling MR, Haas KF, Krauss G, Seif Eddeine H, Henney HR 3rd, Rabinowicz AL, et al. Dosing feasibility and tolerability of intranasal diazepam in adults with epilepsy. Epilepsia. 2014;55(10):1544–50.

    Article  CAS  PubMed  Google Scholar 

  40. Wermeling DP, Record KA, Archer SM, Rudy AC. A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation. Epilepsy Res. 2009;83(2–3):124–32.

    Article  CAS  PubMed  Google Scholar 

  41. Haschke M, Suter K, Hofmann S, Witschi R, Frohlich J, Imanidis G, et al. Pharmacokinetics and pharmacodynamics of nasally delivered midazolam. Br J Clin Pharmacol. 2010;69(6):607–16.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Holsti M, Dudley N, Schunk J, Adelgais K, Greenberg R, Olsen C, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adoles Med. 2010;164(8):747–53.

    Article  Google Scholar 

  43. Bhattacharyya M, Kalra V, Gulati S. Intranasal midazolam vs rectal diazepam in acute childhood seizures. Pediatric Neurol. 2006;34(5):355–9.

    Article  Google Scholar 

  44. de Haan GJ, van der Geest P, Doelman G, Bertram E, Edelbroek P. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia. 2010;51(3):478–82.

    Article  PubMed  Google Scholar 

  45. Thakker A, Shanbag P. A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures. J Neurol. 2013;260(2):470–4.

    Article  CAS  PubMed  Google Scholar 

  46. Reichard DW, Atkinson AJ, Hong SP, Burback BL, Corwin MJ, Johnson JD. Human safety and pharmacokinetic study of intramuscular midazolam administered by autoinjector. J Clin Pharmacol. 2010;50(10):1128–35.

    Article  CAS  PubMed  Google Scholar 

  47. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Eng J Med. 2012;366(7):591–600.

    Article  CAS  Google Scholar 

  48. Silbergleit R, Lowenstein D, Durkalski V, Conwit R. Lessons from the RAMPART study—and which is the best route of administration of benzodiazepines in status epilepticus. Epilepsia. 2013;54(Suppl 6):74–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Scott RC, Besag FM, Boyd SG, Berry D, Neville BG. Buccal absorption of midazolam: pharmacokinetics and EEG pharmacodynamics. Epilepsia. 1998;39(3):290–4.

    Article  CAS  PubMed  Google Scholar 

  50. Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999;353(9153):623–6.

    Article  CAS  PubMed  Google Scholar 

  51. McIntyre J, Robertson S, Norris E, Appleton R, Whitehouse WP, Phillips B, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366(9481):205–10.

    Article  CAS  PubMed  Google Scholar 

  52. Talukdar B, Chakrabarty B. Efficacy of buccal midazolam compared to intravenous diazepam in controlling convulsions in children: a randomized controlled trial. Brain Dev. 2009;31(10):744–9.

    Article  PubMed  Google Scholar 

  53. Malu CK, Kahamba DM, Walker TD, Mukampunga C, Musalu EM, Kokolomani J, et al. Efficacy of sublingual lorazepam versus intrarectal diazepam for prolonged convulsions in sub-saharan Africa. J Child Neurol. 2013;29(7):895–902.

    Article  PubMed  Google Scholar 

  54. Ahmad S, Ellis JC, Kamwendo H, Molyneux E. Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial. Lancet. 2006;367(9522):1591–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Heather McKee has no conflict of interest pertaining to this manuscript. Bassel Abou-Khalil has participated in clinical trials for rectal diazepam, intramuscular diazepam and intranasal midazolam; the research grants were paid to Vanderbilt University, and he has not received any personal funds. There was no funding received for the preparation of this review.

Author information

Authors and Affiliations

  1. Department of Neurology, University of Cincinnati, 222 Piedmont Avenue, Cincinnati, OH, 45219, USA

    Heather Ravvin McKee

  2. Department of Neurology, Vanderbilt University, 1161 21st Avenue South A-0118 MCN, Nashville, TN, 37232, USA

    Bassel Abou-Khalil

Authors
  1. Heather Ravvin McKee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bassel Abou-Khalil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bassel Abou-Khalil.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McKee, H.R., Abou-Khalil, B. Outpatient Pharmacotherapy and Modes of Administration for Acute Repetitive and Prolonged Seizures. CNS Drugs 29, 55–70 (2015). https://doi.org/10.1007/s40263-014-0219-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40263-014-0219-6

Keywords

Search

Navigation